Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 11, 2025

September 11, 2025

EIN Presswire Unveils First Case Study on Using Press Releases to Increase AI Search Visibility and Media Coverage

EIN Presswire

September 11, 2025

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

GlobeNewswire

September 11, 2025

Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List

GlobeNewswire

September 11, 2025

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

GlobeNewswire

September 11, 2025

NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing

GlobeNewswire

September 11, 2025

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

September 11, 2025

Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

GlobeNewswire

September 11, 2025

Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

GlobeNewswire

September 11, 2025

Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results

GlobeNewswire

September 11, 2025

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

GlobeNewswire

September 11, 2025

Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum

GlobeNewswire

September 11, 2025

Pennant Group to Participate in the 2025 Jefferies Healthcare Services Conference

GlobeNewswire

September 11, 2025

Global Pioneer: KFSHRC Showcases Robotic Organ Transplantation Leadership at C3 Davos of Healthcare™ New York Summit

GlobeNewswire

September 11, 2025

Aesthetic Room Opens New Aesthetic Medicine Center in South Tyrol (Alto Adige) Near Merano and Bolzano

GlobeNewswire

September 11, 2025

Global Brain Imaging Devices Market is Projected to Grow at a CAGR of ~6% by 2032 | DelveInsight

GlobeNewswire

September 11, 2025

Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

GlobeNewswire

September 11, 2025

OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer

GlobeNewswire

September 11, 2025

OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites cellules

GlobeNewswire

September 11, 2025

Mount Pleasant Group Becomes First in Canada to Offer Mushroom-Grown Coffins and Urns from Loop Biotech

GlobeNewswire

September 11, 2025

Faraday Pharmaceuticals to Participate in Upcoming Investor Events

GlobeNewswire